 | • レポートコード：MRC2203A418 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の脳深部刺激（DBS）装置市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（シングルチャンネル脳深部刺激装置、デュアルチャネル脳深部刺激装置）分析、用途別（パーキンソン病、本態性振戦、強迫性障害、癲癇、ジストニア）分析、エンドユーザー別（病院、外来手術センター、神経クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の脳深部刺激（DBS）装置市場規模：製品種類別（シングルチャンネル脳深部刺激装置、デュアルチャネル脳深部刺激装置） ・世界の脳深部刺激（DBS）装置市場規模：用途別（パーキンソン病、本態性振戦、強迫性障害、癲癇、ジストニア） ・世界の脳深部刺激（DBS）装置市場規模：エンドユーザー別（病院、外来手術センター、神経クリニック、その他） ・世界の脳深部刺激（DBS）装置市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Abbott Laboratories (St. Jude Medical)、Beijing PINS Medical Co. Ltd、Boston Scientific Corporation、…） ・市場機会・将来傾向 |
The deep brain stimulation devices market is expected to register a CAGR of nearly 12.5% during the forecast period. The major factors driving the growth of the market include the rapidly aging population, which is leading to risk and high prevalence of neurological disorders, growing demand for the devices, due to the rising popularity of minimally invasive procedures, and availability of technologically advanced deep brain stimulation devices.
Key Highlights
- Deep brain stimulation (DBS) is a widely used treatment for advanced Parkinson’s disease (PD), essential tremor, and dystonia. However, over the last three decades, in addition to the extension of its clinical applications, there has been tremendous growth in the DBS technology.
- According to the World Ageing 2019 report, estimates that there were about 703 million population aged 65 years or over in the world in 2019. This number is projected to double to 1.5 billion in 2050. Moreover, by 2050, 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019. As number of elderly population are projected to increase and this population are more prone to neurological disorders which ultimately drives the market in near future.
- Currently, there are multiple DBS systems that have been approved by the European and US regulatory agencies. The US Food and Drug Administration (FDA) approved Boston Scientific Corporation’s Vercise Deep Brain Stimulation (DBS) System. This system is used to treat the symptoms of Parkinson’s disease (PD). Additionally, researchers are enhancing their existing DBS systems, while developing the next-generation devices.
- The researchers are using DBS to target different areas of the brain and studying the treatment in different populations suffering from Parkinson’s disease. Some changes in the new systems have shown improvement in clinical outcomes. Nevertheless, these new developments in the DBS technology are encouraging a large patient community and healthcare providers.
- Hence, all such advancements in the DBS technology have to lead to the growth of the deep brain stimulation devices market.
Key Market Trends
Parkinson’s Disease Segment is Expected to Hold a Major Market Share in the Deep Brain Stimulation Devices Market
The major factor driving the growth of the segment is the rising global prevalence of Parkinson’s disease. According to Parkinson’s Foundation 2018, approximately 1.2 million people in the United States are estimated to suffer from Parkinson’s disease by 2030. It is the second-most common neurodegenerative disorder in the United States. Similarly, as per the estimates of the NHS UK, Parkinson’s disease is found affecting around 1 in 500 people, which means that an estimated 127,000 people in the United Kingdom are suffering from the condition. In addition, there are thousands of patients who go undetected. DBS is the most commonly performed surgical treatment for Parkinson’s disease. It is usually done in people, who have been suffering from Parkinson’s disease for at least four years and have benefits from medications but have motor complications. Additionally, there is a rising technological advancement in the field of DBS, which is propelling the overall growth of the market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
According to the Parkinson’s Foundation Prevalence Project, 930,000 people are estimated to suffer from Parkinson’s disease in the United States, by 2020. The combined direct and indirect costs of Parkinson’s in the United States, including treatment, disability, and similar costs, along with the lost income, owing to the patients’ inability to work, are estimated to be valued at USD 25 billion per year in the United States alone. Hence, the growing burden of Parkinson’s disease on the healthcare system, coupled with uncertain economic conditions in the United States, has forced the original equipment manufacturers (OEMs) to develop cost-effective devices for the treatment of neurological movement disorders.
The US Food and Drug Administration (FDA) approved a deep brain stimulation (DBS) device, namely Brio System, in 2015, for the treatment of Parkinson’s disease and essential tremor. The Brio System’s approval has been good news for the patient community, as it may stimulate more rapid development of the DBS technology.
Additionally, Boston Scientific Corporation received approval from the US Food and Drug Administration (FDA) in December 2017, for its Vercise Deep Brain Stimulation (DBS) System. Hence, all such product approvals and growing incidences of the Parkinson’s disease have helped in driving the growth of the deep brain stimulation devices market.
Competitive Landscape
The deep brain stimulation devices market is consolidated, owing to the presence of a few major market players. Some of the market players are Abbott Laboratories (St. Jude Medical), Beijing PINS Medical Co. Ltd, Boston Scientific Corporation, Fisher Wallace, Functional Neuromodulation Ltd, Medtronic PLC, NeuroPace Inc., and Renishaw PLC.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapidly Aging Population, Leading to Risk and High Prevalence of Neurological Disorders
4.2.2 Growing Demand for the Devices, Due to Rising Popularity of Minimally Invasive Procedures
4.2.3 Availability of Technologically Advanced Deep Brain Stimulation Devices
4.3 Market Restraints
4.3.1 Risks Associated with Deep Brain Stimulation Procedures
4.3.2 Implementation of Government Policies Negatively Affecting the Market
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Single-channel Deep Brain Stimulator
5.1.2 Dual-channel Deep Brain Stimulator
5.2 By Application
5.2.1 Parkinson’s Disease
5.2.2 Essential Tremor
5.2.3 Obsessive Compulsive Disorder
5.2.4 Epilepsy
5.2.5 Dystonia
5.2.6 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Neurological Clinics
5.3.4 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories (St. Jude Medical)
6.1.2 Beijing PINS Medical Co. Ltd
6.1.3 Boston Scientific Corporation
6.1.4 Fisher Wallace
6.1.5 Functional Neuromodulation Ltd
6.1.6 Medtronic PLC
6.1.7 NeuroPace Inc.
6.1.8 Renishaw PLC
7 MARKET OPPORTUNITIES AND FUTURE TRENDS